NRL, a bZIP transcription factor of the Maf subfamily, interacts with the homeodomain protein CRX and synergistically regulates rhodopsin expression. Here we report that six isoforms of NRL (29 -35 kDa) are generated by phosphorylation and expressed specifically in the mammalian retina. The anti-NRL antibody also crossreacts with a cytosolic 45-kDa protein, which is detected in neuronal tissues but is not encoded by the NRL gene. In both human retinal cell cultures and sections of fetal and adult human retina, NRL is present in the nuclei of developing and mature rods but not cones. We propose that NRL regulates rod photoreceptor-specific gene expression and is involved in rod differentiation.
Retinal photoreceptors are highly specialized neurons that capture photons and convert them to chemical signals. Humans and Old World primates have four distinct photoreceptor types, each with a specific visual pigment (1) and a characteristic retinal distribution (2) . Rhodopsin is the photopigment in rod photoreceptors, which dominate primate retina. Rhodopsin provides high sensitivity, but the rod synaptic circuitry yields low spatial resolution. The red, green, and blue visual pigments define the three cone types, whose neural circuits mediate color vision and high spatial resolution but require bright light.
Extensive anatomical, lineage, and birth dating studies have demonstrated that the genesis of specific photoreceptor types from retinal progenitors is guided by intrinsic genetic programs, inductive cell-cell interactions, and extrinsic factors (3) (4) (5) (6) . Postmitotic neurons committed to a photoreceptor cell fate exhibit varying delays before expressing their cell typespecific photopigment, suggesting that the specification of a differentiated rod or cone phenotype requires additional cues (7) (8) (9) (10) . It is envisaged that these inductive cues turn on a "molecular switch," which leads to expression of a specific visual pigment and other components of the transduction machinery.
Cell type-specific gene expression is achieved by combinatorial and synergistic actions of specific activator proteins that recruit the basal transcription machinery to the promoter region (11, 12) . Several transcription factor genes are expressed in retina (13) (14) (15) (16) (17) , and a number of cis-regulatory elements have been identified in retinal gene promoters (18 -20) . However, only two transcription factors, NRL and CRX, have so far been implicated directly in modulating photoreceptor-specific gene expression. NRL was isolated from a subtracted human retinal cDNA library and encodes a basic motif-leucine zipper (bZIP) protein (21) . It displays strong homology to Maf proteins, which are involved in differentiation and gene regulation (22) . NRL was the first transcription factor shown to bind to a cis-regulatory sequence (called NRE or NRL response element) in the rhodopsin promoter and transactivate its activity in cultured cells (23, 24) . CRX is a photoreceptor-and pineal-specific homeodomain protein that appears to modulate several retinal gene promoters (25) (26) (27) . CRX and NRL can physically interact with (28) and synergistically transactivate the rhodopsin promoter (25) , further establishing their roles in photoreceptor gene regulation.
In vivo investigations in rodents (26, 29) and clinical studies in patients with CRX mutations (30 -33) established CRX as a regulator of both cone and rod function. NRL is involved in modulating rhodopsin expression (23, 24, 34, 35) , and missense mutations in NRL cause autosomal dominant retinitis pigmentosa (RP) 1 (36, 37, 54) . To delineate further its biological function, we generated a polyclonal antibody against human NRL, characterized the retinal NRL protein, and localized it in fetal and adult human retinas. We show that multiple isoforms of NRL are generated by phosphorylation and are present in rod but not cone photoreceptor nuclei. We have also identified a novel cytosolic protein, p45, which cross-reacts with anti-NRL antibodies and is detected in neuronal tissues. Based on our data and the phenotype observed in Nrl Ϫ/Ϫ mice, 2 we hypothesize that NRL is required for differentiation and maintenance of the rod photoreceptors in mammalian retina.
EXPERIMENTAL PROCEDURES
Tissues-Adult human eyes (0 -6 h post-mortem) were obtained from the University of Washington, Department of Ophthalmology and Lions Eye Bank (Seattle, WA) and the Ophthalmology Clinic, Strasbourg City Teaching Hospital (Strasbourg, France). Fetal human eyes (within 3 h post-mortem) were obtained from the University of Washington Human Embryology Laboratory. Adult human tissues were also procured from the National Disease Research Interchange (Philadelphia, PA). Retinas from patients with RP were obtained 5-9.5 h post-mortem from the Foundation Fighting Blindness (Hunt Valley, MD). Genetic defects in these RP donors were unknown. The studies followed the tenets of the Declaration of Helsinki and informed consent was obtained from the donors ante-mortem. The research was approved by the human subjects review boards at the participating institutions.
Recombinant Plasmids-The pGEX-NRL construct used for expressing NRL in Escherichia coli was generated by cloning XcmI-HindIII fragment of the human NRL cDNA (21) , encoding the full-length protein (1-237 amino acids), in pGEX-2TK vector (Amersham Pharmacia Biotech) in-frame with glutathione S-transferase (GST). The eukaryotic expression plasmid, pED-NRL, was constructed by cloning XbaIHindIII fragment of the human NRL cDNA in pED vector (36) . All expression constructs were verified by DNA sequencing.
Expression of NRL and Generation of Anti-NRL Antibody-Fulllength NRL was expressed and purified as GST-NRL fusion protein in E. coli (BL21) as described earlier (28) . GST-NRL was cleaved with thrombin (10 units/mg of protein) to separate NRL from the fusion protein. N-terminal amino acid sequencing was performed to confirm the identity of the purified NRL protein before raising polyclonal antibodies (pAb) (Research Genetics, Huntsville, AL). NRL-immobilized membranes were used to affinity purify anti-NRL antibodies (called pAb-NRL).
Preparation of Tissue Extracts and Immunoblot Analysis-Retina and other tissues were sonicated in 20 mM Tris buffer, pH 8.0, containing 150 mM NaCl and a mixture of protease inhibitors (Amersham Pharmacia Biotech). Nuclear and cytoplasmic extracts were prepared from 10 bovine retinas by published procedures (38) . Protein concentration was estimated using bicinchoninic acid reagent (Sigma). Extracts were solubilized in 2ϫ SDS lysis buffer by heating at 100°C for 5 min and separated by SDS-PAGE. Proteins were transferred to nitrocellulose membrane by electroblotting, and immunoblot analysis was performed according to standard protocols (39) .
Transfection and Immunocytochemistry-COS-1 cells were transfected with the pED-NRL expression plasmid using the DEAE-dextran method, as described earlier (23) . After 72 h, cells were harvested for immunoblot analysis. Transfected cells cultured on glass coverslips were processed for immunocytochemistry (40) .
Metabolic Labeling of NRL in COS Cells-72 h after transfection with pED-NRL, the COS-1 cells were incubated for 1 h in either methionine-or phosphate-deficient Dulbecco's modified Eagle's medium. The deficient medium was then replaced by Dulbecco's modified Eagle's medium containing 75 Ci/ml [ 35 S]methionine or 200 Ci/ml 33 P i and incubated for an additional 3 h. Cells were washed in 20 mM Tris buffer, pH 8.0, containing 150 mM NaCl and solubilized in RIPA buffer that included 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium vanadate, 10 mM sodium fluoride, and 1ϫ protease inhibitor mixture (Amersham Pharmacia Biotech).
Phosphatase Treatment-Retinal protein extracts (5 g/l) were incubated in 50 mM Tris buffer, pH 8.0, containing 1 mM MgCl 2 for 10 min at 30°C and then for an additional 20 min at 30°C after adding 20 units of calf intestine alkaline phosphatase (CIAP; Calbiochem). The reaction was terminated by boiling for 5 min in SDS sample buffer and subjected to SDS-PAGE (39) .
Human Retinal Cell Cultures and Immunocytochemistry-Primary cultures were established from post-mortem human retinas, as reported previously (41) . For immunolabeling, cells were fixed in 4% paraformaldehyde in phosphate-buffered saline for 15 min, rinsed in phosphate-buffered saline, permeabilized in 0.1% Triton X-100, and incubated for 15 min in blocking buffer (phosphate-buffered saline containing 0.1% bovine serum albumin, 0.1% Tween 20, 0.1% NaN 3 ). Coverslips were then double immunolabeled with combinations of either pAb-NRL and monoclonal (mAb) anti-rhodopsin (4D2; from Dr. R. Molday), or pAb-NRL and anti-cone mAb (7G6; from Dr. P. MacLeish) (42) , at a final antibody concentration of 10 g/ml for 3 h. Cells were washed with phosphate-buffered saline and incubated in secondary antibodies (goat anti-rabbit IgG-Texas Red for pAb and goat anti-mouse IgG-Bodipy fl for mAb) and DAPI (all from Molecular Probes, Eugene, OR), 10 g/ml for 1 h. Coverslips were washed thoroughly and viewed under differential interference and fluorescence optics with a Nikon Optiphot 2 microscope.
Tissue Preparation and Immunocytochemistry-Five normal adult human retinas and five fetal human retinas at 11, 15.4, 17.4, 19, and 21.5 fetal weeks were cryosectioned at 12 m and processed for immunofluorescence (43) . The secondary antibodies (goat anti-rabbit or antimouse IgG) were labeled with Cy-2 (green), Cy-3 (red), or Cy-5 (blue) (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Nuclei were stained with 1 g/ml propidium iodide (red) (Molecular Probes). Control sections were treated in the same way without the primary antibody or with primary antibody adsorbed with a 50-fold excess of the NRL antigen. The rabbit pAb-NRL (1:1,000 dilution) was used with cell-specific monoclonal antibodies (4D2 at 1:40 dilution and 7G6 at 1:250) in double labeling experiments. Cone subtypes were identified by anti-blue cone opsin (JH455 at 1:5,000 dilution; from Dr. J. Nathans) and anti-red/green cone opsin (1:200 dilution; from Dr. J. Saari). Immunolabeled retinal sections were photographed with a Leica epifluorescence microscope or a Bio-Rad laser scanning confocal microscope.
Immunoblot Analysis of Human RP Retinas-One eye of each pair from RP donors was fixed as above, embedded in JB-4 resin (Polysciences, Wilmington, DE), stained with Richardson's methylene blue/ azure II mixture, and examined by light microscopy to determine which retinal areas contained cones but not rods. The opposite frozen eye of each pair was opened, and the retinal areas identified by light microscopy in the first eye were dissected for immunoblot analysis.
Generation of Nrl Ϫ/Ϫ Mouse-Nrl genomic sequence, derived from the 129SvJ mouse strain, was cloned in pPNT vector (44) to generate the targeting construct, in which the entire Nrl coding region was replaced with the neomycin resistance cassette. This construct was electroporated into R1 embryonic stem cells (45) . Three targeted embryonic stem clones were microinjected into blastocysts. One resulting chimeric male transmitted the targeted allele to the offspring. Heterozygous offspring (Nrl ϩ/Ϫ ) were then interbred to generate the Nrl
mice. Detailed characterization of these mice is reported elsewhere.
RESULTS

Mammalian Retina Expresses Multiple Isoforms of NRL-In both immunoblot and immunoprecipitation experiments, pAb-NRL specifically recognized the NRL protein expressed in E.
coli (data not shown) and transiently transfected mammalian cells (Fig. 1, lane 4) . Immunoblot analysis of mammalian retinal extracts with pAb-NRL detected six proteins at 29 -35 kDa, which migrated as a cluster, and a higher protein of 45 kDa (called p45) (Fig. 1) . These bands were eliminated with preimmune serum or when pAb-NRL was preadsorbed with the antigen (data not shown). These proteins were also identified in Y79 and WERI human retinoblastoma cell lines but not in the kidney cell lines (293 and COS). The 29 -35 kDa bands were not detected in any other human (see Fig. 1 ) or mouse (data not shown) tissue examined. However, p45 was observed in brain tissues (Fig. 1) . 3 In COS cells transfected with the NRL expression construct, only the 29 -35-kDa proteins, but not p45, were identified (Fig. 1) .
Multiple Isoforms of NRL Are Caused by Phosphorylation-To determine if the multiple NRL bands result from post-translational modifications, the human and bovine retinal extracts were treated with different enzymes. CIAP treatment demonstrated a dramatic reduction in 29 -35-kDa proteins with the appearance of a 28 kDa band, which constituted 75% of the total NRL immunoreactivity in the untreated sample ( Fig. 2A) . A similar pattern was observed with phosphatase treatment of extracts from NRL-transfected COS cells (data not shown). The p45 protein (in human retina or in partially purified bovine retinal extracts) remained unchanged by phosphatase treatment ( Fig. 2A) . This also served as an internal control for nonspecific proteolytic degradation in the CIAP assay.
To obtain direct evidence, radiolabeled COS cells transfected with pED-NRL were immunoprecipitated with pAb-NRL and analyzed by SDS-PAGE. (Fig. 2C) , suggesting that all NRL isoforms in transfected COS cells are phosphorylated (Fig. 2, B and C) . Treatment of the immunoprecipitated 33 P-labeled NRL with CIAP abolished Ͼ90% of the radioactivity observed in 29 -35 kDa protein bands (Fig. 2D) .
The p45 Protein Is Enriched in the Cytoplasmic and Membrane Fractions of Retina-To ascertain if various NRL-immu-
noreactive bands show differential subcellular localization, bovine retinal homogenate was subjected to sucrose density gradient ultracentrifugation. The p45 protein was detectable only in the cytoplasmic and not in the nuclear fraction. The 29 -35-kDa NRL isoforms were enriched in the nuclear fraction, and only some of the bands were present in the cytosol (Fig. 3A) . In sonicated bovine retinal extract, the 29 -35-kDa isoforms were present in the soluble fraction and could be precipitated with 10 -50% ammonium sulfate, whereas p45 remained insoluble in the pellet with most of the membrane proteins and could be extracted with the buffers containing non-ionic detergents (see Fig. 2A, lanes 3 and 4) . Isoforms of NRL Are Undetectable in RP Retina-To identify NRL isoforms expressed in rods versus cones, human retinas were obtained from post-mortem eyes of donors with RP, a disease that results initially in rod and later in cone degeneration (46) . Depending on the donor age and genetic subtype, RP retina(s) show varying degree of rod and cone degeneration in peripheral and macular regions (46) . Retinal areas that contained cones but not rods were identified by light microscopy, and corresponding areas were dissected from the opposite frozen eye for immunoblot analysis. Punches from the individual RP retinas were pooled separately. In RP retinas lacking rods, the 29 -35-kDa NRL isoforms were undetectable, and the p45 band was reduced in the intensity compared with normal retinas (Fig. 3B) . The absence of rods in these retinal punches could be correlated to the loss of 29 -35-kDa isoforms. Cones and other retinal cells in RP retinal punches probably contributed to the residual level of the p45 protein (Fig. 3B) .
The Nrl Gene Encodes the 29 -35-kDa Isoforms but Not p45-To confirm the genesis of different NRL-immunoreactive proteins, we performed immunoblot analysis of the retinal extracts from the Nrl Ϫ/Ϫ mice, where the complete Nrl coding sequence was replaced by the neomycin cassette. A complete loss of the 29 -35-kDa isoforms was evident in the homozygous null mouse retina and an equivalent reduction of expression in the heterozygous retina (Fig. 4) . The p45 expression was unaltered in the retina and brain from the Nrl Ϫ/Ϫ mice, establishing that the Nrl gene does not encode p45. This protein apparently shares a common epitope with the NRL protein, resulting in the cross-reactivity of pAb-NRL in immunoblotting and immunocytochemistry.
Expression of Nrl in the Developing Mouse Retina-Previously, Nrl transcripts were identified in developing mouse retina and brain as early as embryonic day 12.5 (34). However, because of possible sequence overlap of Nrl with the putative p45 gene we re-evaluated Nrl expression in developing mouse P. An aliquot of the immunoprecipitate was treated with CIAP for 20 min at 30°C. The reaction was terminated by boiling for 5 min at 100°C in SDS sample buffer. Equal counts were used for SDS-PAGE. Lanes are: 1, untreated 33 P-labeled NRL; 2, CIAP-treated 33 P-labeled NRL.
retina. By immunoblotting, the 29 -35-kDa protein isoforms were detected at birth but increased significantly by postnatal day 3.5, whereas p45 was present at embryonic day 16.5 and did not show temporal changes in expression (Fig. 5) . Identical immunoblots detected the rhodopsin protein later (postnatal day 10) in development. Nuclear Localization of NRL in Transfected COS Cells-In transfected COS-1 cells, NRL was localized primarily to the nucleus (Fig. 6 ). Untransfected cells in the same field or cells transfected with the empty vector DNA in a different well did not show any NRL-positive staining (Fig. 6) . Deletion experiments revealed that the bZIP domain is required for efficient nuclear localization of NRL (data not shown).
Localization of NRL in Cultured Human Retinal Cells and in Adult and
Fetal Human Retina-Primary cultures prepared from post-mortem adult human retinas contained large numbers of rod photoreceptors, as identified by anti-rhodopsin immunolabeling (Fig. 7I, panel C) . Every rhodopsin-positive rod cell had strong NRL immunoreactivity in the nucleus (Fig. 7I,  panel D) , whereas cones (identified by their expression of 7G6) revealed staining only in the cytoplasm (Fig. 7II) . Faint NRL immunoreactivity was observed in the cytoplasm of other cultured retinal neurons, but the retinal glia were unlabeled (Fig.  7I) . Preadsorption of pAb-NRL with the antigen showed no labeling (data not shown).
In adult human retinal sections, pAb-NRL labeled all rod nuclei, but cone nuclei were negative (Fig. 8, A, C, and D) . Cone outer segments as well as rod and cone inner segments, somata, and synapses were also labeled (Fig. 8, A, C, and D) . The cytoplasm of scattered cells in the inner nuclear and ganglion cell layers was weakly NRL-positive (Fig. 8A) . Similar results were obtained with pig retinal sections (data not shown). Sections treated with antigen-adsorbed pAb-NRL showed no labeling (Fig. 8B) .
Because of the steep developmental gradient in fetal retinas (8) , sections cut along the horizontal meridian through the developing macula were studied. All fetal retinas showed a gradient of decreased NRL immunolabeling from the central to peripheral retina. NRL labeling was strongest in the outermost retinal cells near the retinal pigment epithelium (Fig. 8, E-G) . In fetal week 11 retinal sections, the cones in the central retina could be identified by their rounded inner segments. Cone cytoplasm was labeled throughout with mAb 7G6 and pAb-NRL, but the cone nuclei were NRL-negative. Staining of adjacent sections revealed that a few of the central cones were also labeled with anti-blue cone opsin. By 15.4 fetal weeks, some cones labeled with anti-red/green cone opsin in the central retina also had cytoplasm that was positive for pAb-NRL. At 17.4, 19, and 21.5 fetal weeks, cones in the central retina were larger than the rods and lay outermost in the retina, adjacent to the retinal pigment epithelium (Fig. 8, E and G) . Throughout this developmental span, all human fetal cones had pAb-NRL-positive cytoplasm, but their nuclei were negative (Fig. 8, E-G) . The differentiating rods were generally vitread to the cones and had smaller nuclei. In fetal weeks 17.4 and 19 central retina, only a few of the cells that stained positively for NRL in the nucleus were positive for rhodopsin (Fig. 8E) . In the fetal week 19 peripheral retina, many cells in the developing outer nuclear layer had long, thin NRL-positive nuclei but were rhodopsin-negative (Fig. 8F) . These cells may represent newly generated rods (or rod precursors) that had not yet begun to express rhodopsin. By 21.5 fetal weeks, more rods in the central retina had NRL-positive nuclei and rhodopsinpositive cell bodies (Fig. 8G) . 
DISCUSSION
The manifestation of rod versus cone phenotype and function is dependent on the expression of a cell type-specific visual pigment and corresponding proteins of the transduction machinery. Postmitotic photoreceptor precursors exhibit a lengthy time delay of 5-14 days in mouse (10), at least 1 month in primates (9) and up to 2 months in humans (47), before expressing the appropriate opsin. This delay appears to be necessary for achieving "the state of competence" and finalizing the decision to acquire a particular fate (3, 6) . Here, we show that NRL, which is involved in regulating rhodopsin expression, is present in rod but not cone nuclei and is undetectable in RP retinas that lack rods. The temporal expression profile in developing retina, multiple phosphorylated isoforms, and specificity of expression suggest that NRL plays a role in rod differentiation.
In the mammalian retina, the affinity-purified pAb raised against the human NRL protein (pAb-NRL) specifically detects seven protein bands (a cluster of six proteins from 29 to 35 kDa and p45). Of these, the 29 -35-kDa proteins are identified in the retina but not in other human or mouse tissues examined. Several lines of evidence suggest that the 29 -35-kDa proteins are generated from the NRL gene and are the product of posttranslational modification and not alternative splicing or promoter usage. (48 -50) . A number of extracellular signals also exert their influence on cell behavior through protein modifications. Perhaps the most studied of these effectors are phosphorylation and dephosphorylation, which can modulate transcriptional activity by altering nuclear translocation, DNA binding, and/or protein-protein interaction (50, 51) . NRL contains 18 serine and 5 threonine residues that are potential sites for phosphorylation (21, 52). Our data suggest that multiple NRL isoforms in the retina are the result of differential phosphorylation of distinct serine or threonine residues. Detection of identical isoforms in transfected COS cells indicates that although NRL is a rod-specific protein, its phosphorylation is mediated by widely expressed protein kinase(s). Site-directed mutagenesis of selected serine residues (e.g. serine 50, which is mutated in autosomal dominant RP; 36) can dramatically alter the pattern of phosphorylated NRL isoforms in transfected COS cells. 3 However, the mutations in the NRL transactivation domain (including that of serine 50) do not affect its nuclear localization. Distinct NRL isoforms, phosphorylated at different sites, may exhibit varying degrees of interaction specificity with different proteins (e.g. CRX) during transcriptional activation of rod photoreceptor genes. We hypothesize that each phosphorylated isoform has a distinct function in rod gene regulation, as reported for the Mcm1 protein, a Drosophila homologue of the human serum response factor (53) .
During these investigations, we identified a novel protein, p45, which cross-reacts with pAb-NRL but is not encoded by the NRL gene. This suggests that NRL and p45 share a common epitope. A recent search of the human genomic sequence data base revealed that a stretch of 56 residues within the NRL coding region shows Ͼ70% identity to two overlapping putative open reading frames of 368 and 428 amino acids (GenBank accession number AF276758; data not shown). Further investigations are needed to identify the gene that encodes p45, which appears to be expressed only in neuronal tissues. 3 These results also suggest that the previously reported developmental expression profile of the NRL transcripts (34) may indeed represent a combined expression of the NRL and the p45 genes.
Immunocytochemical studies of cultured retinal cells and fixed sections from human retina, together with immunoblotting of RP retinas, reveal that the 29 -35-kDa NRL isoforms are present only in the rod nuclei. The labeling in the cytosol of cones and other neurons is the result of cross-reactivity of p45 with pAb-NRL. Immunoblot analysis of foveal and peripheral retinal punches from monkey retina is consistent with these studies (data not shown). Specific expression of NRL in developing and mature rods and its demonstrated role in rhodopsin regulation strongly argue in favor of an important function for NRL in rod development and maintenance.
In developing mouse retina, Nrl expression precedes the appearance of known markers for differentiated rods and coincides with the birth of postmitotic rod precursors (6, 10) . Because Nrl is a critical determinant of rod cell fate as revealed by the studies of knockout mice, 2 we propose that it is a bona fide marker for rod precursors during retinal differentiation. Isolation and characterization in vitro of NRL-expressing cells from developing retina should provide valuable insights into the molecular events leading to the rod phenotype and function.
